Correspondence 0001193125-24-100772 from Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc.
Date: April 18, 2024 · CIK: 0001863127 · Accession: 0001193125-24-100772
AI Filing Summary & Sentiment
File numbers found in text: 333-278068
Show Raw Text
CORRESP 1 filename1.htm CORRESP Tyra Biosciences, Inc. 2656 State Street Carlsbad, CA 92008 April 18, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Tyra Biosciences, Inc. Registration Statement on Form S-3 File No. 333-278068 To the addressees set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Tyra Biosciences, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on April 22, 2024, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter. Very truly yours, TYRA BIOSCIENCES, INC. By: /s/ Ali Fawaz Ali Fawaz General Counsel cc: Matthew T. Bush, Latham & Watkins LLP